IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
ELI:IBS - Euronext Lisbon - PTIBS0AM0008 - Common Stock - Currency: EUR
IBS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 56 industry peers in the Hotels, Restaurants & Leisure industry. IBS has an average financial health and profitability rating. IBS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
IBS had positive earnings in the past year.
In the past year IBS had a positive cash flow from operations.
Of the past 5 years IBS 4 years were profitable.
In the past 5 years IBS always reported a positive cash flow from operatings.
1.2 Ratios
IBS has a Return On Assets (1.16%) which is in line with its industry peers.
The Return On Equity of IBS (2.54%) is comparable to the rest of the industry.
IBS has a Return On Invested Capital of 3.13%. This is comparable to the rest of the industry: IBS outperforms 44.64% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IBS is significantly below the industry average of 11.15%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 2.54% | ||
| ROIC | 3.13% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
IBS has a Profit Margin (1.74%) which is in line with its industry peers.
IBS's Profit Margin has declined in the last couple of years.
IBS has a Operating Margin of 4.61%. This is comparable to the rest of the industry: IBS outperforms 48.21% of its industry peers.
IBS's Operating Margin has declined in the last couple of years.
IBS's Gross Margin of 49.59% is in line compared to the rest of the industry. IBS outperforms 57.14% of its industry peers.
IBS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.61% | ||
| PM (TTM) | 1.74% | ||
| GM | 49.59% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IBS is destroying value.
Compared to 1 year ago, IBS has less shares outstanding
Compared to 5 years ago, IBS has more shares outstanding
The debt/assets ratio for IBS is higher compared to a year ago.
2.2 Solvency
IBS has an Altman-Z score of 1.94. This is not the best score and indicates that IBS is in the grey zone with still only limited risk for bankruptcy at the moment.
IBS's Altman-Z score of 1.94 is fine compared to the rest of the industry. IBS outperforms 62.50% of its industry peers.
IBS has a debt to FCF ratio of 6.53. This is a slightly negative value and a sign of low solvency as IBS would need 6.53 years to pay back of all of its debts.
IBS's Debt to FCF ratio of 6.53 is in line compared to the rest of the industry. IBS outperforms 58.93% of its industry peers.
IBS has a Debt/Equity ratio of 0.69. This is a neutral value indicating IBS is somewhat dependend on debt financing.
IBS has a better Debt to Equity ratio (0.69) than 67.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 6.53 | ||
| Altman-Z | 1.94 |
ROIC/WACC0.5
WACC6.24%
2.3 Liquidity
IBS has a Current Ratio of 1.09. This is a normal value and indicates that IBS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.09, IBS is doing good in the industry, outperforming 66.07% of the companies in the same industry.
A Quick Ratio of 1.01 indicates that IBS should not have too much problems paying its short term obligations.
The Quick ratio of IBS (1.01) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
IBS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.78%.
IBS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
IBS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.22%.
Measured over the past years, IBS shows a decrease in Revenue. The Revenue has been decreasing by -0.46% on average per year.
EPS 1Y (TTM)-47.78%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%-314.5%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%17.83%
3.2 Future
IBS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.05% yearly.
IBS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.19% yearly.
EPS Next Y32.28%
EPS Next 2Y25.49%
EPS Next 3Y23.64%
EPS Next 5Y26.05%
Revenue Next Year7.14%
Revenue Next 2Y7.41%
Revenue Next 3Y6.44%
Revenue Next 5Y8.19%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 46.90, the valuation of IBS can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of IBS is on the same level as its industry peers.
IBS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.35.
Based on the Price/Forward Earnings ratio of 18.57, the valuation of IBS can be described as rather expensive.
IBS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. IBS is cheaper than 60.71% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.19. IBS is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.9 | ||
| Fwd PE | 18.57 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBS indicates a rather cheap valuation: IBS is cheaper than 80.36% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.14 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
IBS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
IBS's earnings are expected to grow with 23.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.45
PEG (5Y)N/A
EPS Next 2Y25.49%
EPS Next 3Y23.64%
5. Dividend
5.1 Amount
IBS has a Yearly Dividend Yield of 6.97%, which is a nice return.
IBS's Dividend Yield is rather good when compared to the industry average which is at 3.28. IBS pays more dividend than 98.21% of the companies in the same industry.
IBS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.97% |
5.2 History
The dividend of IBS is nicely growing with an annual growth rate of 48.65%!
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBS pays out 242.99% of its income as dividend. This is not a sustainable payout ratio.
The dividend of IBS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP242.99%
EPS Next 2Y25.49%
EPS Next 3Y23.64%
ELI:IBS (6/20/2025, 7:00:00 PM)
9.38
-0.02 (-0.21%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners24.17%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap389.36M
Analysts83.33
Price Target12.56 (33.9%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.97% |
Yearly Dividend0.49
Dividend Growth(5Y)48.65%
DP242.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)12.19%
Min Revenue beat(2)11.28%
Max Revenue beat(2)13.1%
Revenue beat(4)4
Avg Revenue beat(4)8.71%
Min Revenue beat(4)0.18%
Max Revenue beat(4)13.1%
Revenue beat(8)7
Avg Revenue beat(8)6.56%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.36%
PT rev (3m)3.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.9 | ||
| Fwd PE | 18.57 | ||
| P/S | 0.79 | ||
| P/FCF | 8.14 | ||
| P/OCF | 4.94 | ||
| P/B | 1.16 | ||
| P/tB | 1.64 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.2
EY2.13%
EPS(NY)0.51
Fwd EY5.38%
FCF(TTM)1.15
FCFY12.29%
OCF(TTM)1.9
OCFY20.25%
SpS11.85
BVpS8.12
TBVpS5.73
PEG (NY)1.45
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 2.54% | ||
| ROCE | 4.01% | ||
| ROIC | 3.13% | ||
| ROICexc | 4.09% | ||
| ROICexgc | 5.28% | ||
| OM | 4.61% | ||
| PM (TTM) | 1.74% | ||
| GM | 49.59% | ||
| FCFM | 9.73% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
ROICexc(3y)5.24%
ROICexc(5y)N/A
ROICexgc(3y)7.05%
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexcg growth 3Y-24.94%
ROICexcg growth 5Y-3.32%
ROICexc growth 3Y-22.88%
ROICexc growth 5Y-3.24%
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 6.53 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 6.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 560.26% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 1.94 |
F-Score6
WACC6.24%
ROIC/WACC0.5
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.76%
Cap/Sales(5y)11.65%
Profit Quality(3y)200.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.78%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%-314.5%
EPS Next Y32.28%
EPS Next 2Y25.49%
EPS Next 3Y23.64%
EPS Next 5Y26.05%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%17.83%
Revenue Next Year7.14%
Revenue Next 2Y7.41%
Revenue Next 3Y6.44%
Revenue Next 5Y8.19%
EBIT growth 1Y0.48%
EBIT growth 3Y-20.54%
EBIT growth 5Y-7.19%
EBIT Next Year399.89%
EBIT Next 3Y91.9%
EBIT Next 5Y58.09%
FCF growth 1Y-27.17%
FCF growth 3Y-0.14%
FCF growth 5Y-9.32%
OCF growth 1Y-26.24%
OCF growth 3Y1.82%
OCF growth 5Y-6.35%